PSGL-1 restricts HIV-1 infectivity by blocking virus particle attachment to target cells
Open Access
- 28 April 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (17), 9537-9545
- https://doi.org/10.1073/pnas.1916054117
Abstract
P-selectin glycoprotein ligand-1 (PSGL-1) is a dimeric, mucin-like, 120-kDa glycoprotein that binds to P-, E-, and L-selectins. PSGL-1 is expressed primarily on the surface of lymphoid and myeloid cells and is up-regulated during inflammation to mediate leukocyte tethering and rolling on the surface of endothelium for migration into inflamed tissues. Although it has been reported that PSGL-1 expression inhibits HIV-1 replication, the mechanism of PSGL-1-mediated anti-HIV activity remains to be elucidated. Here we report that PSGL-1 in virions blocks the infectivity of HIV-1 particles by preventing the binding of particles to target cells. This inhibitory activity is independent of the viral glycoprotein present on the virus particle; the binding of particles bearing the HIV-1 envelope glycoprotein or vesicular stomatitis virus G glycoprotein or even lacking a viral glycoprotein is impaired by PSGL-1. Mapping studies show that the extracellular N-terminal domain of PSGL-1 is necessary for its anti-HIV-1 activity, and that the PSGL-1 cytoplasmic tail contributes to inhibition. In addition, we demonstrate that the PSGL-1-related monomeric E-selectin-binding glycoprotein CD43 also effectively blocks HIV-1 infectivity. HIV-1 infection, or expression of either Vpu or Nef, down-regulates PSGL-1 from the cell surface; expression of Vpu appears to be primarily responsible for enabling the virus to partially escape PSGL-1-mediated restriction. Finally, we show that PSGL-1 inhibits the infectivity of other viruses, such as murine leukemia virus and influenza A virus. These findings demonstrate that PSGL-1 is a broad-spectrum antiviral host factor with a unique mechanism of action.Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (1R01AI145753)
- HHS | NIH | National Institute of General Medical Sciences (1662096)
This publication has 55 references indexed in Scilit:
- The HIV Envelope but Not VSV Glycoprotein Is Capable of Mediating HIV Latent Infection of Resting CD4 T CellsPLoS Pathogens, 2009
- Surprising up‐regulation of P‐selectin glycoprotein ligand‐1 (PSGL‐1) in endotoxin‐induced uveitisThe FASEB Journal, 2008
- P-selectin Glycoprotein Ligand-1 Decameric Repeats Regulate Selectin-dependent Rolling under Flow ConditionsOnline Journal of Public Health Informatics, 2008
- HIV Envelope-CXCR4 Signaling Activates Cofilin to Overcome Cortical Actin Restriction in Resting CD4 T CellsCell, 2008
- The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu ProteinCell Host & Microbe, 2008
- Tetherin inhibits retrovirus release and is antagonized by HIV-1 VpuNature, 2008
- Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and functionBMC Evolutionary Biology, 2007
- Noncovalent Association of P-selectin Glycoprotein Ligand-1 and Minimal Determinants for Binding to P-selectinOnline Journal of Public Health Informatics, 2000
- P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils.The Journal of cell biology, 1995
- Cytokine Augmentation of HIV-1 LTR-Driven Gene Expression in Neural CellsAIDS Research and Human Retroviruses, 1992